271
Views
12
CrossRef citations to date
0
Altmetric
Infections

Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis

, , ORCID Icon &
Pages 277-282 | Received 02 Jun 2018, Accepted 26 Jul 2018, Published online: 28 Sep 2018

References

  • Ghannoum MA, Hajjeh RA, Scher R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–648.
  • Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88:762–770.
  • Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother. 2012;13:1131–1142.
  • Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 2003;149:1–4.
  • Bristow IR. The effectiveness of lasers in the treatment of onychomycosis: a systematic review. J Foot Ankle Res. 2014;7:34.
  • Ledon JA, Savas J, Franca K, et al. Laser and light therapy for onychomycosis: a systematic review. Lasers Med Sci. 2014;29:823–829
  • Yang Y, Liu H, Yang RY, et al. Efficacy of a superpulse-mode fractional carbon dioxide laser for the treatment of onychomycosis: a clinical observational study. Chinese J Dermatol. 2015;48:526–530.
  • Borovoy M, Tracy M. Noninvasive CO 2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123–124.
  • Bianchi L, Soda R, Diluvio L, et al. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol. 2003;149:207–209.
  • Vyzantiadis TA1, Johnson EM, Kibbler CC. From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification? J Clin Pathol. 2012;65:475–483.
  • Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013; 31:544–554.
  • Haedersdal M, Erlendsson AM, Paasch U, et al. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol. 2015;12:008.
  • Jayatilake JA, Tilakaratne WM, Panagoda GJ. Candidal onychomycosis: a mini-review. Mycopathologia. 2009;168:165–173.
  • Grover S. Clinicomycological evaluation of onychomycosis at Bangalore and Jorhat. Indian J Dermatol Venereol Leprol. 2003;69:284–286.
  • Bramono K, Budimulja U. Epidemiology of onychomycosis in Indonesia: data obtained from three individual studies. Jpn J Med Mycol. 2005;46:171–176.
  • Anane S, Aoun K, Zallagua N, et al. Onychomycosis in Tunis area: epidemiological and mycological data. Ann Dermatol Venereol. 2001;128:733–736.
  • Perea S, Ramos MJ, Garau M, et al. Prevalence and risk factors of Tinea unguium and Tinea pedis in the general population in Spain. J Clin Microbiol. 2000;38:3226–3230.
  • Aghamirian MR, Ghiasian SA. Onychomycosis in Iran: epidemiology, causative agents and clinical features. Nihon Ishinkin Gakkai Zasshi. 2010;51:23–29.
  • Godoy-Martinez P, Nunes FG, Yamashita JT, et al. Onychomycosis in São Paulo, Brazil. Mycopathologia. 2009;168:111–116.
  • Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108–116.
  • Szepietowski JC, Salomon J. Do fungi play a role in psoriatic nails? Mycoses. 2007;50:437–442.
  • Lone R, Showkat HI, Bashir D, et al. Clinicomycological pattern of onychomycosis: a single center one year study in Kashmir-North India. Eur J Gen Med. 2013;10:150–153.
  • Baiu SH, Bridan WMB, Kalfa HMK. Fungi as pathogens of onychomycosis among diabetic patients. J Appl Environ Microbiol. 2016;4:30–33.
  • Lim EH, Kim HR, Park YO, et al. Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol. 2014;70:918–923.
  • Bhatta AK, Keyal U, Huang X, et al. Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. J Am Acad Dermatol. 2016;74:916–923.
  • Campione E, Paterno EJ, Costanza G, et al. Tazarotene as alternative topical treatment for onychomycosis. Drug Des Devel Ther. 2015;9:879–886.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.